CN108315367B - Method for producing creatine phosphate by two-step enzymolysis method - Google Patents

Method for producing creatine phosphate by two-step enzymolysis method Download PDF

Info

Publication number
CN108315367B
CN108315367B CN201810224210.7A CN201810224210A CN108315367B CN 108315367 B CN108315367 B CN 108315367B CN 201810224210 A CN201810224210 A CN 201810224210A CN 108315367 B CN108315367 B CN 108315367B
Authority
CN
China
Prior art keywords
creatine
phospholipase
mixture
biological enzyme
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810224210.7A
Other languages
Chinese (zh)
Other versions
CN108315367A (en
Inventor
买新康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Siwei Biotechnology Co ltd
Original Assignee
Zhengzhou Siwei Health Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Siwei Health Management Co ltd filed Critical Zhengzhou Siwei Health Management Co ltd
Priority to CN201810224210.7A priority Critical patent/CN108315367B/en
Publication of CN108315367A publication Critical patent/CN108315367A/en
Application granted granted Critical
Publication of CN108315367B publication Critical patent/CN108315367B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of sports supplements, and particularly discloses a method for producing creatine phosphate by a two-step enzymolysis method. Taking natural phospholipid as a raw material, adding water, a creatine compound and biological enzyme, and carrying out primary enzymolysis reaction at 40-80 ℃ for 4-72 h; and after the primary enzymolysis reaction is finished, adding phospholipase C, carrying out secondary enzymolysis reaction at 40-80 ℃ for 4-8 h, and purifying to obtain the phosphocreatine. The preparation method does not use any organic solvent such as normal hexane, ethanol, ethyl acetate, acetone and the like, the used raw materials are natural products, and the product has higher physiological activity.

Description

Method for producing creatine phosphate by two-step enzymolysis method
Technical Field
The invention belongs to the technical field of sports supplements, and particularly relates to a method for producing creatine phosphate by a two-step enzymolysis method.
Background
Creatine phosphate is a high-energy phosphate compound phospholipid in muscle or other excitable tissues (such as brain and nerves) and acts to replenish the energy reserve of Adenosine Triphosphate (ATP).
Phosphocreatine is typically synthesized using phosphoenolpyruvate and creatine. The following figures are shown in detail:
Figure 924786DEST_PATH_IMAGE001
however, the raw material phosphoenolpyruvic acid used in the synthesis method is a chemical synthesis product, and an organic solvent is required during synthesis, so that the large-scale production and application of the creatine phosphate as a sports supplement are greatly limited.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide a method for producing creatine phosphate by using natural phospholipid as a raw material through a two-step enzymolysis method.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a method for producing creatine phosphate by a two-step enzymolysis method comprises the following steps: taking natural phospholipid as a raw material, adding water, a creatine compound and biological enzyme, and carrying out primary enzymolysis reaction at 40-80 ℃ for 4-72 h; after the primary enzymolysis reaction is finished, adding phospholipase C, carrying out secondary enzymolysis reaction at 40-80 ℃ for 4-8 h, and purifying to obtain phosphocreatine; wherein the mass ratio of the natural phospholipid to the water to the creatine compound to the biological enzyme to the phospholipase C is 1: 0.1-20: 0.1-4: 0.001-0.1: 0.01-0.1; the enzyme activity of the biological enzyme is more than or equal to 1000U/g, and the enzyme activity of the phospholipase C is more than or equal to 10000U/g.
The natural phospholipid includes but is not limited to one or more of Phosphatidylcholine (PC), Phosphatidylethanolamine (PE), Phosphatidylinositol (PI), Phosphatidylserine (PS), Phosphatidic Acid (PA), Phosphatidylglycerol (PG) and Lysophospholipid (LP).
The natural phospholipid is derived from the following sources (1), (2) or (3):
(1) plants including but not limited to soybean, rapeseed, sunflower;
(2) animals including but not limited to shrimps, fish, birds, mammals, or extracts thereof;
(3) a mixture of two or more of (1) and (2).
The creatine compound comprises but is not limited to one or a mixture of more of anhydrous creatine, hydrate of creatine and salt of creatine.
The biological enzyme includes, but is not limited to, one or a mixture of two of phospholipase D and creatine kinase.
The purification method is a centrifugal filtration method, an organic solvent extraction method or a chromatographic column separation method.
The production method of the invention has the following route schematic diagram:
Figure 841926DEST_PATH_IMAGE002
Figure 808614DEST_PATH_IMAGE003
wherein, R1 and R2 in the natural phospholipid both represent H or fatty acid chain, and X represents small molecule compounds, such as: x = H, the natural phospholipid is phosphatidic acid; x = choline, the natural phospholipid being Phosphatidylcholine (PC); x = ethanolamine, and the natural phospholipid is Phosphatidylethanolamine (PE).
Has the advantages that: the preparation method does not use any organic solvent such as normal hexane, ethanol, ethyl acetate, acetone and the like, the used raw materials are natural products, and the product has higher physiological activity.
Drawings
FIG. 1: the invention relates to a process flow chart of a production method.
Detailed Description
In order to make the invention clearer and clearer, the invention is further described in detail below. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
The process flow diagram is shown in figure 1, and the specific steps are as follows:
adding water, creatine and biological enzyme into a mixture of rapeseed phosphatide (powder) and egg yolk lecithin (powder) (the content of phosphatide in the mixture is 95.6 wt percent through detection), and carrying out enzymolysis reaction for 16 hours at 45 ℃; after the primary enzymolysis reaction is finished, adding phospholipase C, carrying out enzyme reaction for 6 h at 55 ℃, carrying out low-temperature (5 ℃) centrifugal separation, washing and filtering an obtained solid phase for 3 times by using distilled water with the weight being 10 times that of the solid phase to obtain a target product, and detecting by using a high performance liquid chromatography, wherein the content of creatine phosphate in the target product is 90.8%;
wherein the mass ratio of the mixture of the rapeseed phosphatide and the yolk phosphatide (calculated by the content of phosphatide in the mixture) to the water, the creatine, the biological enzyme and the phospholipase C is 1: 10: 1: 0.01; the biological enzyme is a mixture of phospholipase D (enzyme activity 1000U/g) and creatine kinase (enzyme activity 1000U/g) in a mass ratio of 1: 1; the enzyme activity of the phospholipase C is 10000U/g.
Example 2
The process flow diagram is shown in figure 1, and the specific steps are as follows:
adding water, creatine and biological enzyme into soybean concentrated phospholipid (extracted from soybean oil, wherein the content of phospholipid is 60 wt% by detection), and performing enzymolysis reaction at 55 deg.C for 72 h; after the primary enzymolysis reaction is finished, adding phospholipase C, carrying out enzyme reaction for 4h at 60 ℃, carrying out low-temperature (5 ℃) centrifugal separation, washing and filtering an obtained solid phase for 3 times by using distilled water with the weight being 10 times that of the solid phase to obtain a target product, and detecting by using a high performance liquid chromatography, wherein the content of creatine phosphate in the target product is 91.2%;
wherein the mass ratio of the soybean concentrated phospholipid (based on the content of phospholipid) to the water, the creatine, the biological enzyme and the phospholipase C is 1: 0.1: 0.01; the biological enzyme is phospholipase D (enzyme activity is 1000U/g); the enzyme activity of the phospholipase C is 10000U/g.
Example 3
The process flow diagram is shown in figure 1, and the specific steps are as follows:
adding water, creatine and biological enzyme into medulla bovis Seu Bubali extract (phospholipid content is 15.6 wt% detected), and performing enzymolysis at 40 deg.C for 72 hr; after the primary enzymolysis reaction is finished, adding phospholipase C, carrying out enzyme reaction for 4h at 55 ℃, carrying out low-temperature (5 ℃) centrifugal separation, washing and filtering an obtained solid phase for 3 times by using distilled water with the weight being 10 times that of the solid phase to obtain a target product, and detecting by using a high performance liquid chromatography, wherein the content of creatine phosphate in the target product is 90.2%;
wherein the mass ratio of the bovine brain extract (based on the content of phospholipid) to water, creatine, biological enzyme and phospholipase C is 1: 18: 2: 0.01; the biological enzyme is phospholipase D (enzyme activity is 1000U/g); the enzyme activity of the phospholipase C is 10000U/g.

Claims (4)

1. A method for producing creatine phosphate by a two-step enzymolysis method is characterized in that: taking natural phospholipid as a raw material, adding water, a creatine compound and biological enzyme, and carrying out primary enzymolysis reaction at 40-55 ℃ for 16-72 h; after the primary enzymolysis reaction is finished, adding phospholipase C, carrying out secondary enzymolysis reaction at 55-60 ℃ for 4-6 h, and purifying to obtain phosphocreatine; wherein the mass ratio of the natural phospholipid to the water to the creatine compound to the biological enzyme to the phospholipase C is 1: 0.1-20: 0.1-4: 0.001-0.01: 0.01-0.01; the enzyme activity of the biological enzyme is more than or equal to 1000U/g, and the enzyme activity of the phospholipase C is more than or equal to 10000U/g; the creatine compound is one or a mixture of more of anhydrous creatine, hydrate of creatine and salt of creatine; the biological enzyme is one or a mixture of two of phospholipase D and creatine kinase.
2. The production method according to claim 1, wherein: the natural phospholipid is one or a mixture of more of phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, phosphatidic acid, phosphatidylglycerol and lysophospholipid.
3. The production method according to claim 1 or 2, characterized in that: the natural phospholipid is derived from the following sources (1), (2) or (3):
(1) plants including but not limited to soybean, rapeseed, sunflower;
(2) animals including but not limited to shrimps, fish, birds, mammals, or extracts thereof;
(3) a mixture of two or more of (1) and (2).
4. The production method according to claim 1, wherein: the purification method is a centrifugal filtration method, an organic solvent extraction method or a chromatographic column separation method.
CN201810224210.7A 2018-03-19 2018-03-19 Method for producing creatine phosphate by two-step enzymolysis method Active CN108315367B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810224210.7A CN108315367B (en) 2018-03-19 2018-03-19 Method for producing creatine phosphate by two-step enzymolysis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810224210.7A CN108315367B (en) 2018-03-19 2018-03-19 Method for producing creatine phosphate by two-step enzymolysis method

Publications (2)

Publication Number Publication Date
CN108315367A CN108315367A (en) 2018-07-24
CN108315367B true CN108315367B (en) 2021-05-11

Family

ID=62898680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810224210.7A Active CN108315367B (en) 2018-03-19 2018-03-19 Method for producing creatine phosphate by two-step enzymolysis method

Country Status (1)

Country Link
CN (1) CN108315367B (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956069A (en) * 1974-04-29 1976-05-11 Abbott Laboratories Enzymatic assays for glucose, creatine phosphokinase or plasma ammonia
CN1478899A (en) * 2002-08-27 2004-03-03 中国科学院生物物理研究所 Production method of creatine phosphate
CN102533880A (en) * 2010-12-31 2012-07-04 北京百川飞虹生物科技有限公司 Bioengineering method for synthesizing sodium phosphocreatine
CN102653778A (en) * 2012-05-08 2012-09-05 广东省微生物研究所 Enzymolysis preparation method of phosphatidylinositol
CN102808006A (en) * 2012-08-23 2012-12-05 天津启仁医药科技有限公司 Method for producing phosphocreatine by microbial enzyme method
CN103014083A (en) * 2012-12-31 2013-04-03 湖南宝利士生物技术有限公司 Method of preparing creatine phosphate sodium
CN103266126A (en) * 2013-06-06 2013-08-28 上海兆维科技发展有限公司 Method for producing creatine phosphate by using enzyme method
CN105647985A (en) * 2015-04-23 2016-06-08 邦泰生物工程(深圳)有限公司 Method for producing phosphocreatine by biological catalysis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9937239B2 (en) * 2014-05-21 2018-04-10 The Johns Hopkins University Preservation and reconstitution of cell-free protein expression systems

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956069A (en) * 1974-04-29 1976-05-11 Abbott Laboratories Enzymatic assays for glucose, creatine phosphokinase or plasma ammonia
CN1478899A (en) * 2002-08-27 2004-03-03 中国科学院生物物理研究所 Production method of creatine phosphate
CN102533880A (en) * 2010-12-31 2012-07-04 北京百川飞虹生物科技有限公司 Bioengineering method for synthesizing sodium phosphocreatine
CN102653778A (en) * 2012-05-08 2012-09-05 广东省微生物研究所 Enzymolysis preparation method of phosphatidylinositol
CN102808006A (en) * 2012-08-23 2012-12-05 天津启仁医药科技有限公司 Method for producing phosphocreatine by microbial enzyme method
CN103014083A (en) * 2012-12-31 2013-04-03 湖南宝利士生物技术有限公司 Method of preparing creatine phosphate sodium
CN103266126A (en) * 2013-06-06 2013-08-28 上海兆维科技发展有限公司 Method for producing creatine phosphate by using enzyme method
CN105647985A (en) * 2015-04-23 2016-06-08 邦泰生物工程(深圳)有限公司 Method for producing phosphocreatine by biological catalysis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Involvement of phospholipase D in the cAMP-regulated exocytosis of rat parotid acinar cells;Yoko Dohke 等;《Biochemical and Biophysical Research Communications》;20021213;第299卷(第4期);第663-668页 *
固定化肌酸激酶柱连续合成磷酸肌酸工艺;杨志雄 等;《药物生物技术》;20150630;第22卷(第3期);第213-217页 *
磷脂酶D的研究进展;陈石良 等;《工业微生物》;19991231;第29卷(第4期);第47-50页 *

Also Published As

Publication number Publication date
CN108315367A (en) 2018-07-24

Similar Documents

Publication Publication Date Title
CN103555783B (en) A kind of method preparing phosphatidylserine
Yorek Biological distribution
US5965413A (en) Process for producing phosphatidylserines having long chain unsaturated fatty acid as side chain
CN102099453B (en) Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
CN104844647B (en) The preparation method of glycerolphosphocholine
JPH0515719B2 (en)
DE10142014B4 (en) Process for the preparation of phosphatidylserine
FI68158C (en) FOERFARANDE FOER AVSKILJNING AV OLJA OCH / ELLER FOSFATIDYLETANOLAMIN FRAON ALKOHOLLOESLIGA FOSFATIDYLKOLINPRODUKTER INNEHAOLLANDE DESSA
Taffet et al. The calcium uptake of the rat heart sarcoplasmic reticulum is altered by dietary lipid
CN110354144B (en) Sea squirt extract rich in various plasmalogens and preparation and analysis method thereof
Senault et al. Relation between membrane phospholipid composition, fluidity and function in mitochondria of rat brown adipose tissue. Effect of thermal adaptation and essential fatty acid deficiency
AU719509B2 (en) Methods for making lysophosphatidylcholine
JP2019520384A (en) Phospholipid composition
CN108315367B (en) Method for producing creatine phosphate by two-step enzymolysis method
CN102676600A (en) Method for preparing phosphatidylserine
CN104926862B (en) The preparation method of glycerolphosphocholine
Vereschagina et al. The role of exogenous lipids in lycopene synthesis in the mucoraceous fungus Blakeslea trispora
EP1981982A1 (en) Microbial fermentation-based production of phospholipids containing long-chain polyunsaturated fatty acids as their constituents
CN113974017B (en) Feed additive for enriching phosphatidylethanolamine type DHA in eggs, and preparation method and application thereof
EP2151499A2 (en) Processes for the preparation of phosphatides
CN109438508A (en) A kind of preparation method of phosphatidyl-ethanolamine
JP4036595B2 (en) Lipids containing n-4 and / or n-7 polyunsaturated fatty acids and method for producing the same
JP4887674B2 (en) Method for producing phospholipid composition
DE4210611C2 (en) Process for the separation or enrichment of phosphatidylcholine (PC) from or in a phosphatide mixture by extraction
JP2008118902A (en) Method for producing phosphatidylserine containing polybasic unsaturated fatty acid as constituent element

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220428

Address after: 450000 F3 building, No. 1 plant, No. 11, Changchun Road, high tech Industrial Development Zone, Zhengzhou City, Henan Province

Patentee after: Zhengzhou Siwei Biotechnology Co.,Ltd.

Address before: 450000 F3 building, No. 1 plant, No. 11, Changchun Road, high tech Industrial Development Zone, Zhengzhou City, Henan Province

Patentee before: ZHENGZHOU SIWEI HEALTH MANAGEMENT Co.,Ltd.